My Quote Request
No products added yet
6505-01-336-6195
20 Products
TENORMIN TABLETS
ATENOLOL TABLETS,USP
NSN, MFG P/N
6505013366195
NSN
6505-01-336-6195
TENORMIN TABLETS
ATENOLOL TABLETS,USP
NSN, MFG P/N
6505013366195
NSN
6505-01-336-6195
MFG
ASTRAZENECA LP
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ATENOLOL TABLETS 50MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC52268-0200-01
CALCIUM ACETATE TABLETS,USP
NSN, MFG P/N
6505013366181
NSN
6505-01-336-6181
NDC52268-0200-01
CALCIUM ACETATE TABLETS,USP
NSN, MFG P/N
6505013366181
NSN
6505-01-336-6181
MFG
BRAINTREE LABORATORIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 667.000 MILLIGRAMS CALCIUM ACETATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CALCIUM ACETATE TABLETS 667MG 200S BT
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EACH TABLET EQUAL TO 169 MQ (8.45 MEQ) CALCIUM
Related Searches:
NDC59730-6401-01
CALCIUM ACETATE TABLETS,USP
NSN, MFG P/N
6505013366181
NSN
6505-01-336-6181
NDC59730-6401-01
CALCIUM ACETATE TABLETS,USP
NSN, MFG P/N
6505013366181
NSN
6505-01-336-6181
MFG
NABI BIOPHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 667.000 MILLIGRAMS CALCIUM ACETATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CALCIUM ACETATE TABLETS 667MG 200S BT
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EACH TABLET EQUAL TO 169 MQ (8.45 MEQ) CALCIUM
Related Searches:
PHOSLO
CALCIUM ACETATE TABLETS,USP
NSN, MFG P/N
6505013366181
NSN
6505-01-336-6181
MFG
BRAINTREE LABORATORIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 667.000 MILLIGRAMS CALCIUM ACETATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CALCIUM ACETATE TABLETS 667MG 200S BT
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EACH TABLET EQUAL TO 169 MQ (8.45 MEQ) CALCIUM
Related Searches:
CEPTAZ
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505013366182
NSN
6505-01-336-6182
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITH HANGING DEVICE FOR INTERMITTENT INTRAVENOUS ADMINISTRATION
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00173-0416-00
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505013366182
NSN
6505-01-336-6182
NDC00173-0416-00
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505013366182
NSN
6505-01-336-6182
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITH HANGING DEVICE FOR INTERMITTENT INTRAVENOUS ADMINISTRATION
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00173-0442-00
ONDANSETRON HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505013366184
NSN
6505-01-336-6184
NDC00173-0442-00
ONDANSETRON HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505013366184
NSN
6505-01-336-6184
MFG
VETERANS HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS ONDANSETRON HYDROCHLORIDE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ONDANSETRON HYDROCHLORIDE INJECTION 2MG/ML 20ML VIAL
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
Related Searches:
ZOFRAN
ONDANSETRON HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505013366184
NSN
6505-01-336-6184
ZOFRAN
ONDANSETRON HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505013366184
NSN
6505-01-336-6184
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS ONDANSETRON HYDROCHLORIDE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ONDANSETRON HYDROCHLORIDE INJECTION 2MG/ML 20ML VIAL
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
Related Searches:
ZOFRAN INJECTION
ONDANSETRON HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505013366184
NSN
6505-01-336-6184
ZOFRAN INJECTION
ONDANSETRON HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505013366184
NSN
6505-01-336-6184
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS ONDANSETRON HYDROCHLORIDE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ONDANSETRON HYDROCHLORIDE INJECTION 2MG/ML 20ML VIAL
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
Related Searches:
DYNACIRC
ISRADIPINE CAPSULES
NSN, MFG P/N
6505013366188
NSN
6505-01-336-6188
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISRADIPINE CAPSULES 5MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: 5.000MG ISRADIPINE ACTIVEA INGREDIENT
Related Searches:
NDC00078-0227-05
ISRADIPINE CAPSULES
NSN, MFG P/N
6505013366188
NSN
6505-01-336-6188
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISRADIPINE CAPSULES 5MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: 5.000MG ISRADIPINE ACTIVEA INGREDIENT
Related Searches:
DYNACIRC
ISRADIPINE CAPSULES
NSN, MFG P/N
6505013366190
NSN
6505-01-336-6190
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 60.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISRADIPINE CAPSULES 2.5MG 60S BT
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: 2.500MG ISRADIPINE ACTIVE INGREDIENT
Related Searches:
NDC00078-0226-44
ISRADIPINE CAPSULES
NSN, MFG P/N
6505013366190
NSN
6505-01-336-6190
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 60.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISRADIPINE CAPSULES 2.5MG 60S BT
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: 2.500MG ISRADIPINE ACTIVE INGREDIENT
Related Searches:
COLESTID
COLESTIPOL HYDROCHLORIDE FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505013366194
NSN
6505-01-336-6194
COLESTID
COLESTIPOL HYDROCHLORIDE FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505013366194
NSN
6505-01-336-6194
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 GRAMS COLESTIPOL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: COLESTIPOL HYDROCHLORIDE FOR ORAL SUSPENSION USP 300GM BT
PHYSICAL FORM: GRANULE
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITH 5 GRAM DOSE MEASURER
Related Searches:
NDC00009-0260-17
COLESTIPOL HYDROCHLORIDE FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505013366194
NSN
6505-01-336-6194
NDC00009-0260-17
COLESTIPOL HYDROCHLORIDE FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505013366194
NSN
6505-01-336-6194
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 GRAMS COLESTIPOL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: COLESTIPOL HYDROCHLORIDE FOR ORAL SUSPENSION USP 300GM BT
PHYSICAL FORM: GRANULE
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITH 5 GRAM DOSE MEASURER
Related Searches:
NDC00005-3219-34
ATENOLOL TABLETS,USP
NSN, MFG P/N
6505013366195
NSN
6505-01-336-6195
NDC00005-3219-34
ATENOLOL TABLETS,USP
NSN, MFG P/N
6505013366195
NSN
6505-01-336-6195
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ATENOLOL TABLETS 50MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00093-0752-10
ATENOLOL TABLETS,USP
NSN, MFG P/N
6505013366195
NSN
6505-01-336-6195
NDC00093-0752-10
ATENOLOL TABLETS,USP
NSN, MFG P/N
6505013366195
NSN
6505-01-336-6195
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ATENOLOL TABLETS 50MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00364-2513-02
ATENOLOL TABLETS,USP
NSN, MFG P/N
6505013366195
NSN
6505-01-336-6195
NDC00364-2513-02
ATENOLOL TABLETS,USP
NSN, MFG P/N
6505013366195
NSN
6505-01-336-6195
MFG
HENRY SCHEIN INC. DIV SPECIAL MARKETS / FEDERAL SALES
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ATENOLOL TABLETS 50MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00378-0231-10
ATENOLOL TABLETS,USP
NSN, MFG P/N
6505013366195
NSN
6505-01-336-6195
NDC00378-0231-10
ATENOLOL TABLETS,USP
NSN, MFG P/N
6505013366195
NSN
6505-01-336-6195
MFG
MYLAN PHARMACEUTICALS INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ATENOLOL TABLETS 50MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00591-5777-10
ATENOLOL TABLETS,USP
NSN, MFG P/N
6505013366195
NSN
6505-01-336-6195
NDC00591-5777-10
ATENOLOL TABLETS,USP
NSN, MFG P/N
6505013366195
NSN
6505-01-336-6195
MFG
DANBURY PHARMACAL INC SUB OF SCHEIN HENRY INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ATENOLOL TABLETS 50MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
